GlaxoSmithKline's human papilloma virus vaccine has been approved for sale, China Food and Drug Administration told Xinhua on Monday.

In a separate statement, GSK said the vaccine, commercially named Cervarix, is the first HPV vaccine licensed for use in China.

The World Health Organization recommends the appropriate use of HPV vaccine to prevent cervical cancer.